You have 9 free searches left this month | for more free features.

City

Seoul (2)

Busan (1)

Daegu (1)

Daejeon (1)

Incheon (1)

Condition

Diffuse Large B Cell Lymphoma (1)

Lymphocytic Leukemia (1)

Lymphoma, Non-Hodgkin (1)

Multiple Myeloma (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Asan Medical Center (1)

Eisai Korea Inc. (1)

Collaborator

Cheolwon Suh (1)

Intervention

bendamustine, rituximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

Symbenda

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Symbenda Post-Marketing Surveillance (PMS)

Completed

Lymphoma, Non-Hodgkin
+2 more

Busan, Korea, Republic of
+8 more

Jan 25, 2021

Diffuse Large B Cell Lymphoma Trial in Seoul (bendamustine, rituximab)

Recruiting

Diffuse Large B Cell Lymphoma

bendamustine, rituximab

Seoul, Songpa-gu, Korea, Republic of

Asan Medical Center

Apr 24, 2016